New Zealand’s Cancer Society awarded $1M in 2025 grants for cancer research, focusing on early detection, melanoma, and stomach cancer prevention in Māori and Pacific communities.

Okava Pharmaceuticals begins U.S. trial of implantable weight-loss drug for cats to combat pet obesity.

India surpassed its six-year API production target in 3.5 years, boosting self-reliance in essential medicines.

FDA approves Eli Lilly’s Jaypirca for certain leukemia and lymphoma patients previously treated with BTK inhibitors.

Doctors test "butt breathing" — oxygen delivery via rectal enema — as a potential ventilator alternative, showing promise in early trials.

FDA-approved lenses reduce childhood myopia progression by up to 70% over two years.

InsiteOne partners with ASCEND Cardiovascular and Apollo Enterprise Imaging to enhance cardiology imaging and health system interoperability on November 30, 2025.

UBS keeps its Buy rating on Abbott after its acquisition of Exact Sciences, boosting its cancer screening capabilities.

Recce's R327 antibiotic showed strong results in reducing lung infections in early tests.

SoluPet launches its dog cognitive health supplement in Taiwan via partnership with CHC Healthcare.